Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Intelligent Ultrasound unveils portable 'NeedleTrainer Plus'
(Sharecast News) - Intelligent Ultrasound announced a new product on Friday, the portable 'NeedleTrainer Plus' ultrasound-guided needling training simulator, catering to the demands of military field-based hospitals and clinical networks in remote areas. The AIM-traded firm said the system, encased in a durable pelicase, comes equipped with a GE HealthCare Vscan handheld ultrasound device, offering flexibility and accessibility in training scenarios.
It said the NeedleTrainer employs a retractable needle and virtual image overlays to replicate needling procedures on live volunteers, facilitated by real-time ultrasound scans.
The setup would enable trainees to hone their hand-eye coordination, positioning, and precision in ultrasound-guided interventional techniques within a lifelike clinical environment, minimising inherent risks associated with practical training.
This release supplemented Intelligent Ultrasound's expanding portfolio, including the 'ScanNav Anatomy Peripheral Nerve Block', an artificial intelligence (AI)-driven tool aiding healthcare professionals in identifying and annotating anatomy within live ultrasound images.
Particularly tailored for ultrasound-guided regional anaesthesia and analgesia, the technology automatically highlights pertinent anatomy related to common peripheral nerve blocks.
Intelligent Ultrasound explained that ultrasound-guided peripheral nerve block injections had gained traction for postoperative and trauma-related pain management.
Recent findings published in the British Journal of Anaesthesia revealed a 40.4% relative increase in the use of peripheral nerve blocks in trauma cases with the availability of ScanNav Anatomy PNB, indicating enhanced clinical practice without compromising quality of care.
"We hope this new version of NeedleTrainer will support clinicians in more remote areas and help to open up additional markets for our simulators and AI software in the US, UK and through our resellers around the world as we continue to grow our classroom-to-clinic business," said chief executive officer Stuart Gall.
At 1152 GMT, shares in Intelligent Ultrasound Group were up 2.86% at 9p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
